SCHEMBL397351

SCHEMBL397351

CC(C)(C)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.56
ACHE P22303 1/20 0.56
HSD11B1 P28845 2/20 0.54
ALDH1A1 P00352 8/20 0.51
MAPT P10636 5/20 0.51
LMNA P02545 5/20 0.51
RAB9A P51151 4/20 0.51
HTT P42858 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
NPC1 O15118 3/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
HPGD P15428 1/20 0.51
GAA P10253 1/20 0.51
NPBWR1 P48145 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA5A P35218 1/20 0.50
CA9 Q16790 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxymethane SCHEMBL27492761 0.94 ALDH1A1 (0.51) HSD17B10ACHEHSD11B1ALDH1A1MAPT
SCHEMBL2660487 0.94 NPBWR1 (0.54) HSD17B10ACHEHSD11B1ALDH1A1MAPT
Nitrous Acid SCHEMBL29013333 0.90 ALDH1A1 (0.49) HSD17B10ACHEHSD11B1ALDH1A1MAPT
SCHEMBL27496976 0.90 LMNA (0.61) HSD17B10ACHEHSD11B1ALDH1A1MAPT
P-Nitrophenol SCHEMBL28178085 0.90 LMNA (0.61) HSD17B10ACHEHSD11B1ALDH1A1MAPT
SCHEMBL5026702 0.88 MAPT (0.59) HSD17B10ACHEHSD11B1ALDH1A1MAPT
SCHEMBL4670068 0.88 HSPB1 (0.59) HSD17B10ACHEHSD11B1ALDH1A1MAPT
SCHEMBL12415753 0.87 HSD17B10 (0.48) HSD17B10ACHEHSD11B1ALDH1A1MAPT
SCHEMBL2684424 0.87 SRD5A2 (0.62) ALDH1A1MAPTLMNARAB9AHTT
SCHEMBL677959 0.86 HSD17B10 (0.56) HSD17B10ACHEHSD11B1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 588 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118874537-A Catalyst, preparation method thereof and method for preparing aromatic amine compound 厦门大学 2024-11-01 CN claimed
US-10786805-B2 Cadmium sulfide quantum dots NORTHWESTERN UNIVERSITY (US) 2020-09-29 US claimed
US-20160288106-A1 CADMIUM SULFIDE QUANTUM DOTS UNITED STATES DEPARTMENT OF ENERGY 2016-10-06 US claimed
WO-2016153989-A1 CADMIUM SULFIDE QUANTUM DOTS NORTHWESTERN UNIVERSITY (US) 2016-09-29 WO claimed
US-4261926-A REACTION WITH KETONE IN PRESENCE OF PLATINUM HYDROGENATION CATALYST AND A PROMOTER ACID AMERICAN CYANAMID COMPANY (US) 1981-04-14 US claimed
JP-2228360-A None JP disclosed
US-20250388999-A1 HIGH ENTROPY BORIDE-PLATINUM GROUP METAL ALLOYS AND USES THEREOF RES FOUNDATION FOR SUNY (US) 2025-12-25 US disclosed
CN-119661362-A Continuous preparation method of mononitroaromatic hydrocarbon 中国科学院大连化学物理研究所 2025-03-21 CN disclosed
CN-119524841-A Method for preparing nitroso aromatic hydrocarbon, N-hydroxy aromatic amine and aromatic amine from nitroaromatic hydrocarbon 嘉庚创新实验室 2025-02-28 CN disclosed
CN-115354350-B Method for in-situ nitration of electrocatalytic halogenated aromatic hydrocarbon 平顶山学院 2025-02-25 CN disclosed
CN-118874537-A Catalyst, preparation method thereof and method for preparing aromatic amine compound 厦门大学 2024-11-01 CN disclosed
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-31 US disclosed
EP-0381865-A2 Highly processable polyarylene sulfide moulding masses with a high UV stability BAYER AG (DE) 1990-08-16 EP disclosed
US-4892963-A IMMUNE DISEASES LILLY INDUSTRIES LIMITED (GB) 1990-01-09 US disclosed
EP-0257882-A1 N-Phenyl butenamides with pharmaceutical properties LILLY INDUSTRIES LIMITED (GB) 1988-03-02 EP disclosed
EP-0116768-A1 2-(4-Tert.-butyl-2,6-dichlorophenylimino)imidazolidine SMITHKLINE BECKMAN CORPORATION (US) 1984-08-29 EP disclosed
US-4444782-A 2(4-tert.-Butyl-2,6-dichlorophenyl-imino)imidazolidine and use as an anti-hypertension agent SMITHKLINE BECKMAN CORPORATION (US) 1984-04-24 US disclosed
EP-0103990-A1 Process for making diarylamines UNIROYAL, INC. (US) 1984-03-28 EP disclosed
US-4431841-A REACTING PRIMARY AROMATIC AMINES AND ALICYCLIC KETONES USING AN ACID PROMOTER AND A PLATINUM CATALYST UNIROYAL, INC. (US) 1984-02-14 US disclosed
US-4261926-A REACTION WITH KETONE IN PRESENCE OF PLATINUM HYDROGENATION CATALYST AND A PROMOTER ACID AMERICAN CYANAMID COMPANY (US) 1981-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 HSD17B10 1463/4885ACHE 4867/4885HSD11B1 1469/4885
US-20250388999-A1 HIGH ENTROPY BORIDE-PLATINUM GROUP METAL ALLOYS AND USES THEREOF PAX2, AGO2, SLC39A14 HSD17B10 4410/4885ACHE 2039/4885HSD11B1 4348/4885
US-10786805-B2 Cadmium sulfide quantum dots AS3MT, TST, SQOR HSD17B10 1916/4885ACHE 689/4885HSD11B1 1766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.